Key result
IV thiamine reduces PASP by ~21 mmHg within 48 hours in infants with pulmonary hypertension.
Why the study?
Infants exclusively breastfed are at high risk of thiamine-responsive pulmonary arterial hypertension due to low maternal thiamine levels and high metabolic demand, with symptoms sometimes precipitated by comorbidities.
Case Series (n=10)
No
This case series highlights the varied clinical presentations and responses to management in infants with thiamine-responsive pulmonary arterial hypertension.
Answers are grounded in this paper and cite their sources.
May warrant thiamine consideration in select breastfed infants with PAH; leaves open confirmation in prospective trials.
Pulmonary arterial hypertension (PAH) is a progressive disorder caused by hypertension in blood vessels from heart to lungs. Exclusively breastfed infants are at the highest risk due to their high metabolic demand and low thiamine level in mothers. Symptoms are observed to be sometimes precipitated with the presence of co morbidity such as sepsis and lower respiratory tract infections. This study explains 10 cases with varied clinical presentation and response to management of different grades of infantile pulmonary arterial hypertension.
No takes yet. Share an insight, caveat, or question.
Uppalapati et al. (2023) conducted a case series in Pulmonary arterial hypertension (n=10). Thiamine was evaluated on Pulmonary artery systolic pressure (PASP) 24-48 hours after thiamine administration. Intravenous thiamine administration in exclusively breastfed infants with pulmonary arterial hypertension resulted in a mean reduction of pulmonary artery systolic pressure by 21 mmHg within 24-48 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: